Agendia Publishes First Independent Validation Study of Colon Cancer
IRVINE, California and AMSTERDAM, December 15, 2010 /PRNewswire/ —
– Second Independent Validation Study of ColoPrint Selected for Oral Presentation and Press Conference at ASCO GI in January 2011
Agendia, a world leader in molecular cancer…